Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP865203.RAeFxxHF6WZFVBRrPLWJQ_QIHmHIdlwncFHOyP0gJfYEU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP865203.RAeFxxHF6WZFVBRrPLWJQ_QIHmHIdlwncFHOyP0gJfYEU130_assertion type Assertion NP865203.RAeFxxHF6WZFVBRrPLWJQ_QIHmHIdlwncFHOyP0gJfYEU130_head.
- NP865203.RAeFxxHF6WZFVBRrPLWJQ_QIHmHIdlwncFHOyP0gJfYEU130_assertion description "[These effects are distinct from our prior experience with VEGFR2 inhibitors, suggesting that targeting RAF itself or in combination with VEGFR2 induces profound tumor responses in gliomas and may serve as a novel therapeutic approach in patients with malignant gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP865203.RAeFxxHF6WZFVBRrPLWJQ_QIHmHIdlwncFHOyP0gJfYEU130_provenance.
- NP865203.RAeFxxHF6WZFVBRrPLWJQ_QIHmHIdlwncFHOyP0gJfYEU130_assertion evidence source_evidence_literature NP865203.RAeFxxHF6WZFVBRrPLWJQ_QIHmHIdlwncFHOyP0gJfYEU130_provenance.
- NP865203.RAeFxxHF6WZFVBRrPLWJQ_QIHmHIdlwncFHOyP0gJfYEU130_assertion SIO_000772 16951188 NP865203.RAeFxxHF6WZFVBRrPLWJQ_QIHmHIdlwncFHOyP0gJfYEU130_provenance.
- NP865203.RAeFxxHF6WZFVBRrPLWJQ_QIHmHIdlwncFHOyP0gJfYEU130_assertion wasDerivedFrom befree-20150227 NP865203.RAeFxxHF6WZFVBRrPLWJQ_QIHmHIdlwncFHOyP0gJfYEU130_provenance.
- NP865203.RAeFxxHF6WZFVBRrPLWJQ_QIHmHIdlwncFHOyP0gJfYEU130_assertion wasGeneratedBy ECO_0000203 NP865203.RAeFxxHF6WZFVBRrPLWJQ_QIHmHIdlwncFHOyP0gJfYEU130_provenance.